DXC Technology to Participate in Upcoming Investor Conferences
DXC Technology to Participate in Upcoming Investor Conferences
DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences:
- Susquehanna Financial Group’s 2024 Technology Conference – DXC management is hosting a series of investor meetings at the Palace Hotel in New York City on February 29, 2024.
- Morgan Stanley’s 2024 Technology, Media & Telecom Conference – Raul Fernandez, President and CEO, is hosting a fire side chat at 8am PST followed by a series of investor meetings at the Palace Hotel in San Francisco on March 4, 2024. A webcast of the fire side chat will be available on the “Events and Presentations” section of DXC’s investor webpage at https://investors.dxc.com
About DXC Technology
DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. The world’s largest companies and public sector organizations trust DXC to deploy services to drive new levels of performance, competitiveness, and customer experience across their IT estates. Learn more about how we deliver excellence for our customers and colleagues at DXC.com
Source: DXC Technology
Category: Investor Relations
John Sweeney, CFA, Vice President and Head of Investor Relations, +1-980-315-3665, john.sweeney@dxc.com
Sean B. Pasternak, Corporate Media Relations, +1-647-975-7326, sean.pasternak@dxc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220935751/en/
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
What the Fed’s QT Program Is, and Why Its End Matters
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?